salicylic acid has been researched along with vasoactive intestinal peptide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baccari, MC; Cappugi, P; Del Bianco, E; Isolani, D; Rossi, R | 1 |
Bähr, M; Bertolini, M; Bíró, T; Gherardini, J; Kinori, M; Paus, R; Pretzlaff, M; Reibelt, M; Rossi, A; Sulk, M; Uchida, Y | 1 |
2 other study(ies) available for salicylic acid and vasoactive intestinal peptide
Article | Year |
---|---|
Possible involvement of neuropeptidergic sensory nerves in alopecia areata.
Topics: Adolescent; Adult; Alopecia Areata; Biopsy; Calcitonin Gene-Related Peptide; Case-Control Studies; Humans; Injections, Subcutaneous; Laser-Doppler Flowmetry; Microcirculation; Middle Aged; Neurons, Afferent; Neuropeptides; Radioimmunoassay; Scalp; Sensation Disorders; Substance P; Vasoactive Intestinal Peptide | 1997 |
Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse.
Topics: Alopecia Areata; Epithelium; Female; Hair Follicle; Healthy Volunteers; Humans; Interferon-gamma; Pilot Projects; Receptors, Vasoactive Intestinal Peptide, Type II; Receptors, Vasoactive Intestinal Polypeptide, Type I; RNA, Messenger; Scalp; Self Tolerance; Vasoactive Intestinal Peptide | 2016 |